Free Trial

iHuman (NYSE:IH) Issues Earnings Results

iHuman logo with Consumer Discretionary background

iHuman (NYSE:IH - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.07 earnings per share for the quarter, Zacks reports. iHuman had a net margin of 11.44% and a return on equity of 11.01%. The business had revenue of $29.00 million for the quarter.

iHuman Stock Up 5.7%

iHuman stock traded up $0.13 during midday trading on Friday, hitting $2.43. 39,100 shares of the stock were exchanged, compared to its average volume of 39,624. The company has a fifty day simple moving average of $2.28 and a two-hundred day simple moving average of $2.06. iHuman has a 52 week low of $1.47 and a 52 week high of $3.18. The stock has a market capitalization of $126.41 million, a PE ratio of 9.00 and a beta of 0.36.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iHuman stock. Acadian Asset Management LLC acquired a new stake in iHuman Inc. Sponsored ADR (NYSE:IH - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 15,067 shares of the company's stock, valued at approximately $32,000. 4.92% of the stock is owned by institutional investors.

About iHuman

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Featured Articles

Earnings History for iHuman (NYSE:IH)

Should You Invest $1,000 in iHuman Right Now?

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines